Table 1.
Main characteristics of the patients and the findings. ADH: atypical ductal hyperplasia; DCIS: ductal carcinoma in situ; CCA: columnar cell atypia; ER: estrogen receptor; IDC: invasive ductal carcinoma; ILS: invasive lobular carcinoma; LCIS: lobular carcinoma in situ; PgR: progesterone receptor; UDH: usual ductal hyperplasia.
| Breast Cancers: | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Age | BIRADS | Biopsy | Diagnosis | Grade | TNM | Stage | ER | PgR | Ki67 | Her2 |
| 41 | B4c | B5 | IDC + DCIS | G2 | pT1a pN0 | IA | 90 | 90 | 10 | 1+ |
| 45 | B4b | B5 | IDC | G3 | pT1a pN0 | IA | 0 | 0 | 60 | 3+ |
| 46 | B4a | B5 | DCIS | G3 | pTis | 0 | + | / | / | / |
| 46 | B4b | B4 | IDC tubular | G1 | pT1a pN0 | IA | 90 | 60 | 10 | 1+ |
| 47 | B4c | B5 | DCIS | G1 | pTis | 0 | 40 | 1 | 5 | 1+ |
| 48 | B4c | B5 | DCIS | G1 | pTis pN0 | 0 | + | / | / | / |
| 50 | B4b | B5 | DCIS | G1 | pTis | 0 | + | / | / | / |
| 50 | B4c | B5 | ILC | G1 | pT1b pN0 | IA | 95 | 95 | 3 | 0 |
| 51 | B4c | B5 | DCIS | G1 | pTis | 0 | - | / | / | / |
| 51 | B4b | B3 | DCIS + ADH | G1 | pTis | 0 | + | / | / | / |
| 53 | B4a | B5 | DCIS | G1 | pTis | 0 | 30 | 10 | / | / |
| 53 | B4c | B5 | DCIS | G3 | pTis pN0 | 0 | 80 | 2 | 20 | 0 |
| 53 | B4b | B4 | DCIS | G2 | pTis | 0 | 0 | 0 | 90 | 0 |
| 54 | B4c | B5 | IDC + DCIS | G3 | pT1c pN0 | IA | 90 | 2 | 30 | 2+/0 |
| 54 | B5 | B5 | DCIS | G2 | pTis pN0 | 0 | 40 | 3 | 30 | 3+ |
| 54 | B4b | B5 | DCIS | G3 | pTis | 0 | 0 | 0 | 75 | 0 |
| 55 | B4b | B5 | IDC tubular | G1 | pT1a pN0 | IA | 70 | 60 | 10 | 0 |
| 56 | B4a | B5 | CDIS | G1 | pTis | 0 | + | / | / | / |
| 56 | B4c | B5 | IDC NST + DCIS | G1 | pT1c pN0 | IA | 90 | 70 | 10 | 3 |
| 56 | B4c | B5 | DCIS | G3 | pTis pN0 | 0 | 0 | 0 | / | / |
| 56 | B4b | B5 | IDC | G2 | pT1b pN0 | IA | 90 | 90 | 15 | 0 |
| 57 | B4a | B5 | DCIS + ADH | G1 | pTis pNx | 0 | 80 | 10 | / | / |
| 57 | B4b | B5 | DCIS multifocal | G3 | pTis pN0 | 0 | 0 | 0 | 50 | 3+ |
| 58 | B4a | B5 | DCIS | G3 | pTis pN0 | 0 | 0 | 0 | 20 | 3+ |
| 60 | B4b | B5 | DCIS | G3 | pTis | 0 | 90 | 2 | 10 | 2+ |
| 60 | B4c | B5 | DCIS | G3 | pTis pN0 | 0 | + | / | / | / |
| 62 | B4a | B5 | LCIS | G2 | pLis | 0 | 90 | / | / | / |
| 62 | B4b | B5 | DCIS | G2 | pTis pN0 | 0 | 100 | 100 | / | / |
| 62 | B4c | B5 | DCIS + ADH | G1 | pTis pNx | 0 | + | / | / | / |
| 62 | B4b | B5 | DCIS | G1 | pTis pNx | 0 | 80 | 80 | 2 | 1+ |
| 63 | B4b | B5 | DCIS | G1 | pTis pN0 | 0 | 70 | 70 | 5 | 2+ |
| 66 | B4c | B5 | DCIS | G3 | pTis pN0 | 0 | 80 | 10 | / | / |
| 66 | B3 | B5 | DCIS | G1 | pTis pNx | 0 | 90 | 20 | 10 | 1+ |
| 69 | B4b | B5 | DCIS | G3 | pT1mic pN0 | IA | 90 | 80 | 25 | 1+ |
| 70 | B4c | B5 | ILC | G2 | pT1c pN1mi | IA | 70 | 80 | 25 | 0 |
| 70 | B4b | B5 | DCIS | G3 | pTis | 0 | + | / | / | / |
| 72 | B4c | B5 | DCIS | G3 | pT1mi pN0 | IA | 80 | 20 | 20 | 2+ |
| B3 lesions after surgery: | ||||||||||
| 49 | B4a | B3 | Sclerosing adenosis with CCA and ADH | |||||||
| 49 | B4a | B3 | UDH and ADH | |||||||
| 50 | B4a | B3 | Florid adenosis, UDH and CCA | |||||||
| 53 | B4b | B3 | ADH | |||||||
| 53 | B4a | B3 | ADH with UDH | |||||||
| 56 | B4c | B3 | ADH | |||||||
| 58 | B4c | B3 | Radial scar with atypia and papilloma | |||||||
| 59 | B4a | B3 | ADH | |||||||
| 59 | B4b | B3 | ADH | |||||||
| 67 | B4b | B3 | UDH with ADH | |||||||
| 69 | B4b | B3 | ADH | |||||||
Benign findings are mainly represented by the following lesions: sclerosing adenosis without atypia, UDH, apocrine metaplasia and fibrosis.